echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Long-term follow-up clinical guidelines plan to release CDE high-profile escort gene therapy products

    Long-term follow-up clinical guidelines plan to release CDE high-profile escort gene therapy products

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The good curative effect of gene therapy products has been artificially led by industry insiders to lead the third industrial revolution of biomedicine
    .


    On June 4, 2021, the official website of the Center for Drug Evaluation of the National Medical Products Administration issued the "Technical Guidelines for Long-term Follow-up Clinical Research of Gene Therapy Products (Draft for Comment)", and the deadline is July 4, 2021


    1.
    Why are there special guidelines for long-term follow-up of gene therapy products?

    1.
    Why are there special guidelines for long-term follow-up of gene therapy products?

    Gene therapy: refers to a therapeutic method that modifies or manipulates the expression of genes or changes the biological characteristics of living cells to achieve the purpose of treatment.
    The main mechanism of action is the replacement of disease-causing genes with normal genes, inactivation of genes that cannot work normally, or introduction of new ones.
    Or modified genes
    .


    These changes in the biological properties of living cells exist for a long time in the body and may increase unpredictable risks


    The main purpose of the long-term follow-up of gene therapy products is to collect the delayed adverse reactions of subjects and understand the existence of gene therapy products in the body, so as to identify and reduce the long-term risk of patients receiving gene therapy products
    .


    In addition, taking into account the characteristics of the long-term effects of gene therapy products, observing the changes in the efficacy over time is also an important purpose of long-term follow-up


    2.
    Long-term follow-up observation time for gene therapy products

    2.
    Long-term follow-up observation time for gene therapy products

    The duration of the long-term follow-up should be sufficient to observe the risks of the subject due to product characteristics, exposure (biodistribution and route of administration), etc.
    , and should not be shorter than the expected occurrence of delayed adverse reactions
    .


    The follow-up time of a specific product depends on the characteristics of the product and the existence time in the body, the time of transgene expression, the expected time and incidence of late adverse reactions, the indications and expected survival period of the subject, the route of administration, and other long-term follow-up Observe the purpose


    3.
    Long-term follow-up risk assessment strategies for gene therapy products

    3.
    Long-term follow-up risk assessment strategies for gene therapy products

    At present, the development of gene therapy products is gaining momentum.
    According to reports, there are more than 2,000 gene therapy clinical trials in progress worldwide
    .


    However, it can also have long-term or permanent effects on the human body.


    references

    [1] http://

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.